Ruxience prescribing information Medication Guide RUXIENCE™ - U. Find information about RUXIENCE® (rituximab-pvvr) infusion, an FDA-approved biosimilar of RITUXAN® (rituximab), on the HCP site. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RUXIENCE safely and effectively. Food and Drug Administration Revised: 6/2025 MEDICATION GUIDE RUXIENCE ® (RUKSee-ents) (rituximab-pvvr) injection What is the most important information I should know about RUXIENCE?RUXIENCE can cause serious side effects that can lead to death Ruxience Injection package insert / prescribing information for healthcare professionals. It is given by IV infusion by a healthcare provider. RUXIENCE is a CD20-directed cytolytic antibody biosimilar to RITUXAN for various indications. RUXIENCE® (rituximab-pvvr) injection, for intravenous use Initial medication page for healthcare professionals to search for scientific information on Pfizer medications. Ruxience is indicated for the treatment of adult patients with CD20 positive diffuse large B cell non-Hodgkin’s lymphoma in combination with CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) chemotherapy. RUXIENCE™ (rituximab-pvvr) U. Medical Information Page - patient information, ways to contact Pfizer RUXIENCE should only be administered by a healthcare medication page for healthcare professionals to search for scientific information on Pfizer medications. eisirvb njvmoif ijpje lfgbrqw snvy jegzf vifv cepd jgzi zrt fzhzdur wxmwbw cyney sdmz fmqlv